You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
8 March 2022
NEC OncoImmunity Acquires VAXIMM’s Neoantigen Vaccine Development Assets
27 May 2021
VAXIMM to Attend International Scientific and Industry Events
4 May 2021
VAXIMM Announces Participation at Scientific and Industry Events in May
18 March 2021
VAXIMM to Participate at Upcoming Scientific and Industry Events
8 July 2020
VAXIMM Appoints Thomas D. Szucs, MD, as Chairman of the Board
14 May 2020
VAXIMM Announces First Results from Phase I/II Trial in Progressive Glioblastoma with Oral T-cell Immunotherapy VXM01 in Combination with PD-L1 Inhibitor Avelumab to be Presented at ASCO20 Virtual